Position in QGEN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,401
-$32,394 QoQ
Shares Held
87
-90.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#291
of 332 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Manchester Capital Management LLC holds $4,315,962 across 16 Diagnostics & Research names. QGEN ranks #12 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LH |
Labcorp Holdings Inc.
|
4,170 | $1,167,600 | |
| 2 | WAT |
Waters Corp /De/
|
3,011 | $1,129,245 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
1,979 | $992,191 | |
| 4 | DHR |
Danaher Corp /De/
|
3,278 | $624,393 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
158 | $201,846 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
114 | $60,014 | |
| 7 | A |
Agilent Technologies, Inc.
|
328 | $43,568 | |
| 8 | ILMN |
Illumina, Inc.
|
165 | $29,011 |
All Filings in QGEN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,401 | 87 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $35,795 | 894 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $42,361 | 942 | Shares | Sole | 2026-02-11 | |
| 2024-12-31 | $7,570 | 170 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $7,746 | 170 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $6,533 | 159 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $6,835 | 159 | Shares | Sole | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||